ACADIA Pharmaceuticals
ACAD
#3173
Rank
NZ$8.85 B
Marketcap
NZ$51.40
Share price
4.03%
Change (1 day)
20.97%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2026 (TTM): NZ$0.19 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$1.09 Billion. In 2025 the company made an earning of NZ$0.23 Billion a decrease over its 2024 earnings that were of NZ$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.19 B-17.44%
2025 NZ$0.23 B-46.18%
2024 NZ$0.43 B-605.67%
2023 -NZ$86.92 Million-76.09%
2022 -NZ$0.37 Billion27.41%
2021 -NZ$0.29 Billion-40.38%
2020 -NZ$0.48 Billion19.88%
2019 -NZ$0.4 Billion-3.92%
2018 -NZ$0.42 Billion-15.04%
2017 -NZ$0.49 Billion6.33%
2016 -NZ$0.46 Billion64.55%
2015 -NZ$0.28 Billion77.47%
2014 -NZ$0.16 Billion143.69%
2013 -NZ$64.63 Million81.93%
2012 -NZ$35.53 Million-8.73%
2011 -NZ$38.92 Million-251.39%
2010 NZ$25.7 M-133.2%
2009 -NZ$77.44 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$83.55 Million36.99%
2005 -NZ$60.99 Million37.22%
2004 -NZ$44.45 Million19.96%
2003 -NZ$37.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.24 B 22,469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.03 B 9,101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.00 B 26,940.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.34 B 8,237.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-NZ$0.28 Billion-239.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-NZ$65.79 Million-133.56%๐Ÿ‡บ๐Ÿ‡ธ USA